Paper sludge typically taken to landfills (50%), incinerated (20%) or spread on land as soil enhancement (10%). In total, there’s 8 million wet tonnes (4MT dry) of paper sludge that costs $240 million each year to truck and landfill. In this project , researchers propose to develop a technology for converting the carbohydrates in paper […]
Renewable natural gas (RNG) is typically produced from biogas using gas separation technology – keeping the CH4 – venting the CO2. Upgrading CO2 present in biogas using naturally-occurring organisms can increase production 60 – 70%. In this project, researchers aimed to develop, innovate, reduce costs and de-risk the biomethanation process to upgrade biogas sources to […]
Most current wastewater plants recover <33% of incoming energy & have a negative energy balance. So, there’s an opportunity to increase net energy yield from municipal wastewater treatment. Yet, Anaerobic membrane bioreactors (AnMBRs) facilitate mainstream anaerobic digestion but previous AnMBRs suffer from high costs and energy inputs. A research team proposed a project to resolve […]
Energy production from sewage sludge especially at small-scale using Anaerobic Digestion (AD) typically does not produce significant value with the current available AD technology due to low Carbon Conversion Efficiency (CCE) (generally less than 50%). A research team proposed a novel concept, which will overcome this problem and produce significant more energy in the form […]
A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]
A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]
A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]
A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]
A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]
A handful of industrial biotechnology companies have the strength and purpose to make it as a public company — others remain private, are acquired, or wind down. What makes companies able to succeed with public investors? What combination of product mix, experienced management, technologies that excel, capital at work, and effective vision make it possible […]
